Validity of PCNA immunostaining in normal and tumor cells: Comparison with Ki-67 labeling

Journal of Histotechnology

Volumn 22, Issue 4, 1999, Pages 287-293

  Yerly Motta, V ^a   Pavy, J J ^b   Bosset, S F ^b   Arbez Gindre, F ^b   Herve, P ^a  

^a Cellular Immunology Laboratory   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Cell cycle; DNA synthesis; Fixation; Flow cytometry; Proliferation marker; Tumor proliferation

Indexed keywords

ACETONE; KI 67 ANTIGEN; METHANOL; PARAFORMALDEHYDE;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0032740624     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1179/his.1999.22.4.287     Document Type: Article

References (55)

1. Coltrera MD, Gown AM: PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem 39:23-30, 1991
2. Pavy JJ, Wilson GD: Le temps de doublement potentiel. Aspects techniques. Bull Cancer/Radiothe 80:425-431, 1993
3. Wilson GD, McNally NJ, Disches S et al: Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 58:423-431, 1988
4. Begg AC, McNally NJ, Shrieve DC, Kärcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6:620-626, 1986
5. Wilson MS, West CML, Wilson GD et al: An assessement of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer 67:754-759, 1993a
6. Baisch H, Otto U: Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry. Cell Prolif 26:439-448, 1993
7. Begg AC: The clinical status of Tpot as a predictor? or why no tempest in the Tpot! Int J Radiation Oncot Biol Phys 32:1539-1541, 1995
8. Perez LA, Dombkowski D, Efird J et al: Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements. Cancer Res 55: 392-399, 1995
9. Wilson MS, West CML, Wilson GD et al: Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer 68:501-506, 1993b
10. Celis JE, Bravo R, Mose Larsen P, Fey SJ: Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 8:143-157, 1984
11. Zölzer F, Streffer C, Pelzer T: A comparison of different methods to determine cell proliferation by flow cytometry. Cell Prolif 27:685-694, 1994
12. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H: Cyclin/ PCNA is the auxiliary protein of DNA polymerase-d. Nature 326:515-517, 1987a
13. Prelich G, Tan CK, Kostura M et al: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein. Nature 326:517-519, 1987
14. Torres-Ramos CA, Yoder BL, Burgers PMJ et al: Requirement of proliferating cell nuclear antigen in RAD6-dependent postreplicational DNA repair. Proc Nad Acad Sci USA 93: 9676-9681, 1996
15. Kurki P, Vanderlaan M, Dolbeare F et al: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-215, 1996
16. Lohr F, Wenz F, Haas S, Flentje M: Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrdlabelling index under different proliferative conditions in vitro by flow cytometry. Cell Prolif 28:93-103, 1995
17. Bravo R, MacDonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105: 1549-1554, 1987b
18. Czader M, Porwit A, Tani E et al: DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Mod Pathol 8:51-58, 1995
19. Kakeji Y, Maehara Y, Adachi Y et al: Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma. Br J Cancer 69:749-753, 1994
20. Kawase N, Shiokawa A, Ota H et al: Nucleolar organizer regions and PCNA expression in prostatic cancers. Pathol Int 44:213-222, 1994
21. Volm M, Koomagi R, Mattern J: Prognostic significance of proliferating cell nuclear antigen (PCNA) in adenocarcinoma of the lung, Int J Oncol 6:359-364, 1995
22. Willett CG, Warland G, Cheek R et al: Proliferating cell nuclear antigen and mitotic activity in rectal cancer: predictor of response to preoperative irradiation. J Clin Oncol 12:679-682, 1994
23. Baum HP, Reichrath J, Theobald A, Schock G: Fixation requirements for the immunohistochemical reactivity of PCNA antibody PC10 on cryostat sections. Histochem J 26:929-933, 1994
24. Beppu T, Ishida Y: Detection of S phase cells with an antibody to proliferating cell nuclear antigen (PCNA). J Histotechnol 17:325-328, 1994
25. Casasco A, Casasco M, Cornaglia AI et al: Tissue fixation for immunohistochemical detection of proliferating cell nuclear antigen with PC10 monoclonal antibody. Biotech Histochem 69:112-117, 1994
26. Sasaki K, Kurose A, Shibata Y, Matsuta M: Varying detection of PCNA in solid tumor cells: effects of fixation and detergent. J Histotechnol 18:31-36, 1995
27. Wada T, Shimabukuro T, Matsuyama H et al: Optimal conditions of fixation for immunohistochemical staining of proliferating cell nuclear antigen in tumour cells and its cell cycle related immunohistochemical expression. Cell Prolif 27:541-550, 1994
28. Wilson MS, Schofield PF: Correlation of PCNA with bromodeoxyuridine. Gut 35:717, 1994
29. Galand P, Del Bino G, Morret M et al: PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes. Leukemia 9:1075-1084, 1995
30. Lynch DAF, Clarke AMT, Jackson P et al: Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol 47:122-126, 1994
31. Gerdes J, Lemke H, Baish H et al: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715, 1984
32. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20, 1983
33. Gerdes J, Lelle RJ, Pickartz H et al: Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 39:977-981, 1986
34. Palutke M, Kukuruga D, Tabaczka P: A flow cytometric method for measuring lymphocyte proliferation directly from tissue culture plates using Ki-67 and propidium iodide. J Immunol Met 105:97-103, 1987
35. Sasaki K, Matsumura K, Tsuji T et al: Relationship between labeling indices of Ki-67 and BrdU in human malignant tumors. Cancer 62:989-993, 1988
36. Sasaki K, Kurose A, Ishida Y: Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects on the inhibition of DNA synthesis on it. Cytometry 14:876-885, 1993
37. Sullivan RP, Mortimer G: Value of PCNA and Ki67 staining in breast cancer. J Clin Pathol 46:188-192, 1993
38. Galand P, Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22:383-392, 1989
39. Landberg G. Roos G: Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 51:4570-4578, 1991
40. Nakane PK, Moriuchi T, Koji T et al: Proliferating cell nuclear antigen (PCNA/cyclin): review and some new findings. Acta Histochem Cytochem 22:105-116, 1989
41. Ohyama S, Yonemura Y, Miyazaki I: Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application. Cancer 69:314-321, 1992
42. Kubben F, Peeters-Haesevoets A, Engels L et al: Proliferating cell nuclear antigen (PCNA): a new marker to study human colonie cell proliferation. Gut 35:530-533, 1994
43. Risio M, Candelaressi G, Rossini FP: Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence. Cancer Epidemiol Biomark Prev 2:363-369, 1993
44. Weisgerber UM, Boeing H, Nemitz R et al: Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonie epithelium. Gut 34: 1587-1592, 1993
45. Bruno S, Darzynkiewicz Z: Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL60 cells. Cell Prolif 25:31-38, 1992
46. Sasaki K, Murakami T, Kawasaki M, Takahashi M: The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 133:579-577, 1987
47. Kovac D, Rubinic M, Krasevic M et al: Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer. Anticancer Res 15:2301-2302, 1995
48. Tanaka S, Haruma K, Tatsuta S et al: Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. Oncology 52:134-140, 1995
49. Yao T, Tsurieyoshi M, Matsumoto T et al: Depressed adenoma of the colorectum: analysis of proliferative activity using immunohistochemical staining for proliferating cell nuclear antigen (PCNA). Pathol Int 44:520-527, 1994
50. Ray R, Tahan SR, Andrews C, Goldman H: Stromal tumors of the stomach: prognostic value of the PCNA index. Mod Pathol 7:26-34, 1994
51. Suehiro T, Matsumata T, Itasaka H et al: Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 76:399-409, 1995
52. Karkavelas G, Mavropoulou S, Fountzilas G et al: Correlation of proliferating cell nuclear antigen assessement, histologic parameters and age with survival in patients with glioblastoma multiforme. Anticancer Res 15:531-536, 1995
53. Pich A, Ponti R, Valente G et al: MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol 47:18-22, 1994
54. Gillett CE, Barnes DM, Camplejohn RS: Comparison of three cell cycle associated antigens as markers of proliferating activity and prognosis in breast carcinoma. J Clin Pathol 46: 1126-1128, 1983
55. Keshgegian AA, Cnaan A: Proliferation markers in breast carcinoma mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am J Clin Pathol 104:42-49, 1995